Skip to main content

Table 4 Correlation between POL η expression and clinicopathologic characteristics of gastric cancer patients

From: DNA polymeraseη protein expression predicts treatment response and survival of metastatic gastric adenocarcinoma patients treated with oxaliplatin-based chemotherapy

characteristic

POLη

χ2 test

P value

Fisher's test

P value

 

Positive

(n = 23)

Negative

(n = 57)

  

Age(y)

    

   < 60

16

37

0.690

0.797

   ≥ 60

7

20

  

Gender

    

   Male

14

35

0.695

1.000

   Female

9

22

  

Primary sites

    

   Cardia

10

11

0.084

0.102

   Body

4

14

  

   Antrum/pylorus

9

32

  

Metastatic sites

    

   Liver

11

15

0.247

0.269

   Lung

5

16

  

   Peritoneum

3

16

  

   Others

4

10

  

Pathologic differentiation

    

   G1

2

0

0.068

0.107

   G2

6

20

  

   G3

15

37

  

Treatment Response

    

   CR+PR+SD

7

55

< 0.001

< 0.001

   PD

16

2

  
  1. CR, complete response; PR, partial response; SD, stable disease; PD, progression disease.
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us